TheEdgeResearch
Home / Stocks / NNOX

Nano-X Imaging Ltd. (NNOX)

NASDAQ Healthcare Medical - Devices
$0.23 ▼ -2.17%
Market Cap
$17.7M
Sector
Healthcare
Industry
Medical - Devices
Beta
1.36
52-Wk Range
0.207-4.71
CEO
Erez I. Meltzer
Country
IL
Currency
USD

Nano-X Imaging Ltd. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Petah Tikva, IL. The stock last traded at $0.23, down 2.17% on the session, giving a market capitalisation of $17.7M. On trailing twelve-month figures it carries a trailing P/E of -0.13, a net margin of -747.2%. Its beta of 1.36 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.13
Price / Sales
1.13
Price / Book
0.22
EV / EBITDA
0.06
Gross margin
-338.2%
Operating margin
-654.9%
Net margin
-747.2%
Return on equity
—
Debt / equity
0.11
Current ratio
2.84
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Market
Employees
197
IPO date
2020-08-21
Headquarters
Petah Tikva, IL
About Nano-X Imaging Ltd.

Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.

Comparable companies

Nano-X Imaging Ltd. is most often compared with the following Healthcare names:

CATXHCATHSDTINGNMXCTOMPROFQTRXSNWVTLSI
More research on NNOX
NNOX technical analysis NNOX TheEdge Score Compare against peers
Open full interactive analysis & DCF →